Cell therapy manufacturing in Puerto Rico
CytoImmune Biologics manufactures autologous cell therapies in an ISO 7 cleanroom suite at the University of Puerto Rico’s Molecular Sciences Research Center in San Juan.
Manufacturing
We take cell therapies from process development and technology transfer through manufacturing and release testing.
ACP-01 for Hemostemix
CytoImmune is the contract manufacturer for ACP-01, the autologous stem cell therapy developed by Hemostemix Inc., under a Manufacturing Services Agreement announced in August 2024.
NK cell research
CytoImmune was founded on natural killer (NK) cell research from the laboratories of Drs. Michael A. Caligiuri and Jianhua Yu, and that research continues with them today.